Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults.

Authors :: Dreyzin A
Jacobsohn D
Angiolillo A
Wistinghausen B
Schore RJ
Perez E
Wells E
Terao J
Bonifant C
Rohatgi R
Dave H
Vatsayan A
Source :: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2022 May; Vol. 39 (4), pp. 370-378. Date of Electronic Publication: 2021 Oct 21.
Publication Year :: 2022

Subjects :: Administration, Intravenous
Child
Humans
Receptors, Antigen, T-Cell
Young Adult
Interleukin 1 Receptor Antagonist Protein adverse effects
Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy

Full Text Access

Tools